Clinical Trial

An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

Completed
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and improve health outcomes in AYA with SCD.
Protocol Amendment History 4 changes
critical Trial completed 2026-08-01
notable Enrollment reduced: 40 -> 36 participants 2026-08-01
notable Primary completion pushed: 2025-02-01 -> 2025-09-16 2026-08-01
minor Completion pushed: 2025-02-01 -> 2025-09-16 2026-08-01
Trial Details
NCT Number NCT04688411
Lead Sponsor Ann & Robert H Lurie Children's Hospital of Chicago
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Sickle Cell Disease, Sickle Beta Zero Thalassemia, Sickle B+ Thalassemia, Sickle Cell Hemoglobin C
Enrollment 36 participants
Start Date 2020-09-28
Primary Completion 2025-09-16 (estimated)
Study Completion 2025-09-16 (estimated)
Updated on ClinicalTrials.gov 2026-07-31